Could this Energy Stock really climb 112.11% by 2024?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [AI "wealth window" will close January 9, 2024?]( Next-generation AI technology will create the first $100 TRILLION industry. AI 2.0 will open a brief “wealth window”… That will slam shut January 9, 2024. [>>HERE is everything you need now<<]( --------------------------------------------------------------- November 10, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Is This "Royalty Strategy" the Most Overlooked Way to Play Gold?]( are catching on to a little-known strategy that has been quietly funding gold miners... This "royalty strategy" offers investors certain advantages over other gold vehicles, such as bullion, ETFs, and stocks. It provides investors exposure to rising gold prices and mining success - without all the operational risks and costs. [Read this startling report on a huge untapped opportunity]( --------------------------------------------------------------- [Tower]( Symbol: [TSEM]( Recent Price: $24.20 Average Analyst Price Target: $36.50 (50.83%) Market Cap: $2.66B Last Year's EPS: $0.41 Consensus EPS Forecast: $0.49 Expected Earnings Date: Nov 13 2023 Recent Analyst Action: Cody Acree, analyst at Benchmark Co., reiterates coverage on [Tower (TSEM)]( in the Technology sector with a Buy rating and a price target of $35 (2 weeks ago). [TipRanks.com]( also reports that [Tower]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $36.50 . The target pricing ranges from a high forecast of $38 down to a low forecast of $35. [Tower (TSEM)](’s last closing price was $24.20 which would put the average price target at 50.83% upside. Here are 3rd party ratings for [TSEM](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [GPT-4 vs. X.AI: The Race of the New AI Giants]( smart money investors all know AI is the wave of the future and could mean huge profits for anyone involved. AI has been called the biggest new industry of the 21st century. Experts are projecting it will be worth a staggering $80 trillion over the next 10 years. And right now, Chief Investment Strategist Adam O’Dell is revealing his favorite X.AI stock you should check out today. [Click here to see the full story now.]( --------------------------------------------------------------- [Rumble]( Symbol: [RUM]( Recent Price: $4.71 Average Analyst Price Target: $10.00 (112.31%) Market Cap: $1.91B Last Year's EPS: -$0.1 Consensus EPS Forecast: -$0.13 Expected Earnings Date: Nov 13 2023 Recent Analyst Action: Tom Forte, analyst at D.A. Davidson, reiterates coverage on [Rumble (RUM)]( in the Technology sector with a Buy rating and a price target of $10 (4 days ago). [TipRanks.com]( also reports that [Rumble]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.00 . The target pricing ranges from a high forecast of $10 down to a low forecast of $10. [Rumble (RUM)](’s last closing price was $4.71 which would put the average price target at 112.31% upside. Here are 3rd party ratings for [RUM](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 22% (54 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Fisker]( Symbol: [FSR]( Recent Price: $3.79 Average Analyst Price Target: $9.20 (137.47%) Market Cap: $1.50B Last Year's EPS: -$0.38 Consensus EPS Forecast: -$0.31 Expected Earnings Date: Nov 13 2023 Recent Analyst Action: Itay Michaeli, analyst at Citi, reiterates coverage on [Fisker (FSR)]( in the Consumer Cyclical sector with a Buy rating and a price target of $10 (1 week ago). [TipRanks.com]( also reports that [Fisker]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $9.20 . The target pricing ranges from a high forecast of $9 down to a low forecast of $10. [Fisker (FSR)](’s last closing price was $3.79 which would put the average price target at 137.47% upside. Here are 3rd party ratings for [FSR](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 34% (165 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [AI to Disrupt Energy Market (Huge Potential Gains!)]( orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… It makes them all look like small fries… In fact, just one year of this untapped resource in the USA alone provides 5X as much power as the largest oil field on Earth… And this resource is about to be unleashed on the world like never before with the help of one tiny Silicon Valley company…[Click here for all the details…]( --------------------------------------------------------------- [OPAL Fuels]( Symbol: [OPAL]( Recent Price: $5.70 Average Analyst Price Target: $12.27 (112.11%) Market Cap: $1.01B Last Year's EPS: -$0.06 Consensus EPS Forecast: -$0.003 Expected Earnings Date: Nov 13 2023 Recent Analyst Action: Paul Cheng, analyst at Scotiabank, reiterates coverage on [OPAL Fuels (OPAL)]( in the Energy sector with a Buy rating and a price target of $10.55 (1 month ago). [TipRanks.com]( also reports that [OPAL Fuels]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $12.27 . The target pricing ranges from a high forecast of $5.8 down to a low forecast of $10.55. [OPAL Fuels (OPAL)](’s last closing price was $5.70 which would put the average price target at 112.11% upside. Here are 3rd party ratings for [OPAL](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 44% (140 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Beauty Health]( Symbol: [SKIN]( Recent Price: $3.72 Average Analyst Price Target: $13.75 (244.09%) Market Cap: $568.75M Last Year's EPS: -$0.04 Consensus EPS Forecast: $0.05 Expected Earnings Date: Nov 13 2023 Recent Analyst Action: Susan Anderson, analyst at Canaccord Genuity, reiterates coverage on [Beauty Health (SKIN)]( in the Consumer Cyclical sector with a Buy rating and a price target of $10 (2 days ago). [TipRanks.com]( also reports that [Beauty Health]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $13.75 . The target pricing ranges from a high forecast of $8 down to a low forecast of $10. [Beauty Health (SKIN)](’s last closing price was $3.72 which would put the average price target at 244.09% upside. Here are 3rd party ratings for [SKIN](: - TipRanks.com: Strong Buy - TradingView.com: Strong Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Buy, Top 26% (64 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [CEO Gets One Up on Public Investors With Secret $3 Stock]( aren't supposed to know about this [secret $5 stock](... If word gets out, the CEO will have a much harder time taking over the tech world... And Wall Street's already buying billions of dollars worth of shares... How long will you stay in the dark? [Click here to learn more.]( --------------------------------------------------------------- [ProKidney]( Symbol: [PROK]( Recent Price: $1.67 Average Analyst Price Target: $15.50 (858.08%) Market Cap: $378.76M Last Year's EPS: -$0.16 Consensus EPS Forecast: -$0.41 Expected Earnings Date: Nov 13 2023 Recent Analyst Action: Justin Zelin, analyst at BTIG, reiterates coverage on [ProKidney (PROK)]( in the Healthcare sector with a Buy rating and a price target of $16 (4 weeks ago). [TipRanks.com]( also reports that [ProKidney]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $15.50 . The target pricing ranges from a high forecast of $16 down to a low forecast of $15. [ProKidney (PROK)](’s last closing price was $1.67 which would put the average price target at 858.08% upside. Here are 3rd party ratings for [PROK](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Buy, Top 34% (86 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Biora Therapeutics]( Symbol: [BIOR]( Recent Price: $1.49 Average Analyst Price Target: $50.00 (3,255.70%) Market Cap: $39.19M Last Year's EPS: -$1.59 Consensus EPS Forecast: -$1.6 Expected Earnings Date: Nov 13 2023 Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on [Biora Therapeutics (BIOR)]( in the Healthcare sector with a Buy rating and a price target of $50 (2 weeks ago). [TipRanks.com]( also reports that [Biora Therapeutics]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $50.00 . The target pricing ranges from a high forecast of $50 down to a low forecast of $50. [Biora Therapeutics (BIOR)](’s last closing price was $1.49 which would put the average price target at 3,255.70% upside. Here are 3rd party ratings for [BIOR](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Forget Tesla... Apple Car May Be The #1 EV Play]( Valley insider, Luke Lango, says his contacts are going crazy over Apple's latest project. Apple is preparing to upend the auto industry with their own EV... and this $5 stock could soar 40X once it goes live! [Click here to learn more.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketInsidersPress.com MarketInsidersPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketInsidersPress.com MarketInsidersPress.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville NC | 28115 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software